Back to Invesco Ltd. Invesco Ltd.

HRTXHRTX
Showing 8 of 23 quarters

Position history for Invesco Ltd.Invesco Ltd.'s holdings in HERON THERAPEUTICS INC

Invesco Ltd. holds 406,668 shares of HRTX (HERON THERAPEUTICS INC), worth $173,565 as of 2026-Q2. The position was increased (+24.6% shares).

Current Value

$173,565

Current Shares

406,668

Total Value Change

+$70,759

Total Shares Change

+355,007

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
406,668
+24.6%
$173,5650.0%$0.43
19
2026-Q1
Increased
326,512
+6.1%
$261,2430.0%$1.15
17
2025-Q4
Increased
307,861
+33.0%
$400,2200.0%$1.35
21
2025-Q3
Increased
231,395
+33.7%
$291,5580.0%$1.27
20
2025-Q2
Increased
173,081
+44.6%
$358,2780.0%$2.14
32
2025-Q1
Increased
119,662
+67.6%
$263,2570.0%$2.26
23
2024-Q4
Increased
71,399
+38.2%
$109,2410.0%$1.51
20
2024-Q3
Increased
51,661
+25.0%
$102,8060.0%$1.99
18

Other major holders of HRTX: FRANKLIN RESOURCES INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used